Friday, May 1, 2026

Hyundai Bioscience’s CEO will Join the President’s Economic Delegation to Vietnam

Hyundai Bioscience partners with Bepharco for antiviral drug distribution in Vietnam and accelerates cancer treatment trials.

Seoul’s New Prime Minister Begins U.S. Diplomacy Push With Washington, New York Visit

Prime Minister Kim Min Seok will visit the U.S. from January 22-26, focusing on strengthening U.S.-South Korea relations.

Anthropic vs. OpenAI: Who Will Dominate the Corporate AI Market in 2026?

Anthropic partners with private equity firms to boost AI adoption and secure semiconductor infrastructure amid rising competition.

Tag: ophthalmic treatments

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us